Chargement en cours...
VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced NASH model in mice
Non-alcoholic fatty liver disease (NAFLD) and its advanced stage, non-alcoholic steatohepatitis (NASH), are the most common causes of chronic liver disease in the United States. NASH features the metabolic syndrome, inflammation, and fibrosis. Probiotics exhibit immunoregulatory and anti-inflammator...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3756672/ https://ncbi.nlm.nih.gov/pubmed/19115316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.22711 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|